You've been missing the most important number in diabetes.
Glucose tells you what happened. Your insulin sensitivity tells you why. Mirri brings that hidden metric into focus — so you finally see what's actually driving your numbers.
For type 2 diabetes, prediabetes, and anyone serious about metabolic health.
Glucose is only half the story.
Carb counts and glucose readings show you the symptoms. The thing underneath them — how well your body responds to insulin — is where type 2 is actually won or lost. And almost nothing tracks it.
The lagging indicators
- •Glucose. A snapshot of what already happened.
- •Carbs. An input, not an outcome.
- •A1C. A three-month average, months too late.
The number underneath
- •Insulin sensitivity. How efficiently your body uses insulin.
- •The real driver. It shapes your glucose, energy, and weight.
- •Changeable. It responds to sleep, movement, and food — today.
The dial your body runs on.
Your insulin sensitivity shifts every single day — with how you slept, how you moved, your stress, and what you ate. When it's high, everything gets easier. When it drops, your numbers fight back. Mirri makes that invisible shift visible.
See your sensitivity trend
Track how your insulin sensitivity moves day to day and week to week — a signal you've never been able to watch before.
Know what moves the needle
Connect sleep, activity, stress, and meals to real changes in your sensitivity — and learn what your body responds to.
Understand the why
Turn raw glucose data into decisions you can actually act on — less guesswork, more understanding, real momentum.
Built for type 2 — and anyone paying attention.
Insulin resistance doesn't start at a diagnosis, and it doesn't stop being important after one. Whether you're managing type 2, watching prediabetes, or simply serious about staying metabolically healthy for the long run — insulin sensitivity is the lever. Mirri hands it to you.
Start seeing what you've been missing.
Mirri is in development. Join the early-access list and be first to bring your insulin sensitivity into focus.
Join the early-access list